SBI Shinsei Corporate Investment
VC Fund
Tokyo, Japan
SBI Shinsei Corporate Investment is an investment company that manages funds with disciplined and rational judgment in venture investments and buyout investments.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries SBI Shinsei Corporate Investment invests in
Stages SBI Shinsei Corporate Investment invests in
Countries SBI Shinsei Corporate Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.5M–$3.5M
- Venture - Series Unknown
- $2.4M–$3.2M
Investment Focus
Industry
- Apps 1 (13%)
- Energy 1 (13%)
- Retail 1 (13%)
- Medical 1 (13%)
- Nuclear 1 (13%)
Stage
- Series A 3 (38%)
- Venture - Series Unknown 2 (25%)
- Series B 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kenji Uesaka
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
|
Noriyuki Yamada
Senior Director
|
Senior Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AOI Biosciences is a biotechnology company that creates testing and drug discovery businesses. | $3.2M / Venture - Series Unknown / Sep 14, 2026 | ||
| Think Nature is a researcher startup that specializes in the solutions related to the sustainability of biodiversity and ecosystem services. | $2.4M / Venture - Series Unknown / Apr 01, 2026 | ||
| Light is a software development company that allows streamers and viewers to connect in real time through an application. | $3.1M / Series B / Dec 23, 2025 | ||
| EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation. | $2.6M / Series A / Oct 14, 2025 | ||
| The company was founded in October 2019 by Dr. Takaki, a Japanese intensivist with more than 20-year experience in critical care medicine, from his strong desire of wanting to decrease preventable death and sudden changes in patient conditions while in the ICU. CROSS SYNC’s vision is to provide ICU-level medical treatment anywhere. The mission isto help and assist medical professionals utilizing the power of technology so that they can provide high-quality medical care even in an environment where there is a shortage of specialist physicians, and to ensure the best patient outcomes. As a Yokohama University certified startup, CROSS SYNC develops a variety of AI clinical assistant tools in collaboration with affiliated hospitals, the school of medicine, and the department of health data science. By delivering our AI-based platform to acute care settings all over the world, we aim to create a world without avoidable deaths and preventable acute changes for in-patients. | $1.5M / Series A / Oct 06, 2025 | ||
| Wunderbar provides intellectual property along with branding and marketing services. | $3.5M / Series A / Jun 25, 2025 | ||
| See all 8 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does SBI Shinsei Corporate Investment invest in?
SBI Shinsei Corporate Investment invests primarily in Apps, Energy and Retail startups, most often at Series A and Venture - Series Unknown stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is SBI Shinsei Corporate Investment's check size?
SBI Shinsei Corporate Investment typically joins rounds of $1.5M–$3.5M at Series A and $2.4M–$3.2M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SBI Shinsei Corporate Investment participates in.
How do I contact SBI Shinsei Corporate Investment?
Public channels for SBI Shinsei Corporate Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SBI Shinsei Corporate Investment?
The team at SBI Shinsei Corporate Investment includes Kenji Uesaka (President & CEO) and Noriyuki Yamada (Senior Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
